Moldova latest patents query
The latest invention patents collect the data information of Moldova invention patents from 2000 to 2024, typesetting according to the date of patent publication, including patent number, application date, invention Bibliographic data, abstracts, and specification data of people are convenient for scientific researchers to quickly browse and search for patents.
Cancer combination therapy using aza bicyclic compound and antiandrogen agent
PendingMDE20260513A1
Owner:TAIHO PHARMA CO LTD
Anti-AAV2.7m8 antibodies and methods of use thereof
PendingMDE20260678A1
Owner:ADVERUM BIOTECHNOLOGIES INC
Method of measuring and suppressing carbon dioxide in oil and gas geologies
PendingMDE20260612A1
Owner:COSTANZA HOLDINGS LLC
Solid elacestrant dihydrochloride compositions, methods of making the same, and methods of treatment using the same
PendingMDE20260289A1
Owner:BERLIN CHEMIE AG
Bispecific PD-L1x4-1BB antibodies and methods of use thereof
PendingMDE20260397A1
Owner:REGENERON PHARMACEUTICALS INC
Estetrol for use in the prevention and treatment of Alzheimer's disease
PendingMDE20260428A1
Owner:ESTETRA SRL
Methods of treating cancer with a combination of a PD1 inhibitor and a targeted immunocytokine
PendingMDE20260641A1
Owner:REGENERON PHARMACEUTICALS INC
Compositions and methods comprising small nuclear RNA (snRNA) for treating genetic epilepsies
PendingMDE20260688A1
Owner:REGENERON PHARMACEUTICALS INC
Composition for the use in the treatment of polycystic ovary syndrome
PendingMDE20260008A1
Owner:LO LI PHARMA SRL
Hydrometallurgical method of production - recovery of copper from copper oil sludge, using new, organic and inorganic, synthetic aqueous solutions and geopolymer materials
PendingMDE20260551A1
Owner:ARGYROPOULOS SOKRATIS
Methods for treating chronic inflammatory demyelinating polyneuropathy
PendingMDE20260398A1
Owner:ARGENX BVBA(BE)
Methods and compositions for producing ovarian support cell co-culture
PendingMDE20260126A1
Owner:GAMETO INC
A crystalline form of 2-(3-(2,,5'-difluoro-[1,1'-biphenyl]-4-yl)-2-oxotetrahydropyrimidin-1(2H)-yl)-4-methylthiazole-5-sulfonamide
PendingMDE20260537A1
Owner:ASSEMBLY BIOSCIENCES INC
BCMA-targeted CAR-T cell therapy for multiple myeloma
PendingMDE20260172A1
Owner:LEGEND BIOTECH USA INC +1
Relaxin-2 fusion protein analogs and methods of using same
PendingMDE20260256A1
Owner:TECTONIC OPERATING CO INC
Methods of treating cancers and enhancing efficacy of t cell redirecting therapeutics
PendingMDE20260423A1
Owner:JANSSEN BIOTECH INC +1
Mivelsiran compositions and methods of use thereof
PendingMDE20260216A1
Owner:ALNYLAM PHARMACEUTICALS INC
Self-emulsifying composition and self-emulsifying preparation containing sulfonamide derivative
PendingMDE20260145A1
Owner:EA PHARMA CO LTD
Composition for improving the aesthetic appearance of hair and skin appendages
PendingMDE20260026A1
Owner:GIULIANI SPA
Methods of treating chronic graft-versus-host disease using an anti-colony stimulating factor 1 receptor antibody
PendingMDE20260412A1
Owner:INCYTE CORP
A multi-page document with security features integrating pages thereof and a method of securing such a document
PendingMDE20260636A1
Owner:POLSKA WYTWORNIA PAPIEROW WARTOSCIOWYCH
Solid forms of a macrocyclic farnesyltransferase inhibitor and formulations thereof, and methods of preparing and using the macrocyclic compound and its solid forms
PendingMDE20260290A1
Owner:KURA ONCOLOGY INC
Gem-disubstituted piperidine melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof
PendingMDE20260196A1
Owner:CRINETICS PHARMACEUTICALS INC
Spirocyclic dihydropyranopyrimidine KRas inhibitors
PendingMDE20260523A1
Owner:TREELINE BIOSCIENCES INC
5,6 Unsaturated bicyclic heterocyles useful as inhibitors of NOD-like receptor protein 3
PendingMDE20260291A1
Owner:MERCK SHARP & DOHME LLC
The system, device and procedure in dynamic optimisation and stabilisation of the electrical grid using a multilevel additive-increase / multiplicative-decrease (AIMD) method
PendingMDE20250936A1
Owner:ISKRAEMECO MERJENJE IN UPRAVLJANJE ENERGIJE D D
Withaferin A analog and method for treatment using the same
PendingMDE20260628A1
Owner:ENVEDA THERAPEUTICS INC
Benzo nitrogen-containing heterocyclic derivative regulator, preparation method therefor and use thereof
PendingMDE20260456A1
Owner:SHANGHAI HANSOH BIOMEDICAL CO LTD +1
Combination therapy involving macrocyclic indazole compounds
PendingMDE20260349A1
Owner:BLOSSOMHILL THERAPEUTICS INC
CD40 x CD40 bispecific antigen-binding molecules and uses thereof
PendingMDE20260318A1
Owner:REGENERON PHARMACEUTICALS INC
Winding machine with automatic introduction of reinforcing sheet
PendingMDE20260299A1
Owner:IMS TECH SPA
Multi-layer electrospun micro / nanofibrous membranes based on marine sulfated polysaccharides for periodontal tissue / bone regeneration
PendingMDE20260084A1
Owner:UNI-PHARMA KLEON TSETIS PHARMACEUTICAL LABORATORIES SA GR +1
Vacuum suction cup based on snap-on type gasket structure
PendingMDE20260420A1
Owner:ZHEJIANG SHIJING TOOLS CO LTD
Cancer therapy including 3,5-disubstituted benzene alkynyl compound and immune checkpoint inhibitor
PendingMDE20260542A1
Owner:TAIHO PHARMA CO LTD
Fused bicyclic heterocyclyl compounds as CCR4 modulators
PendingMDE20260212A1
Owner:AURIGENE ONCOLOGY LIMITED
Method for controlling parasitic weeds (Orobanche) in Protoporphyrinogen Oxidase (PPO)-inhibitor tolerant sunflower crop
PendingMDE20260116A1
Owner:BASF AGRO BV
Low pH pharmaceutical composition comprising T cell engaging antibody constructs
PendingMDE20260595A1
Owner:AMGEN RESEARCH (MUNICH) GMBH +1
Anti-IL-13 multispecific antibody constructs and uses thereof
PendingMDE20260508A1
Owner:PROTEOLOGIX US INC
Method for using the T cell repertoire as a predictive and prognostic biomarker in cancer
PendingMDE20260635A1
Owner:FRONTIER VERTEX SRL +1
Compositions and methods for silencing carbonic anhydrase 2 expression
PendingMDE20260524A1
Owner:ALNYLAM PHARMACEUTICALS INC
Antibody-drug conjugates using two different types of topoisomerase I inhibitors
PendingMDE20260346A1
Owner:ARARIS BIOTECH AG
Tricyclic quinolone and 1,8-naphthyridin-2-one BCL6 bifunctional degraders
PendingMDE20260545A1
Owner:TREELINE BIOSCIENCES INC
Dosage regime of crinecerfont for treating congenital adrenal hyperplasia
PendingMDE20260133A1
Owner:NEUROCRINE BIOSCIENCES INC
Pan-ELR+ CXC chemokine antibodies for the treatment of hidradenitis suppurativa
PendingMDE20260187A1
Owner:ELI LILLY & CO
Peptides with lipolytic, anti-lipogenic, antifibrotic and anti-inflammatory activity
PendingMDE20260278A1
Owner:FUNDACIÓ HOSPITAL UNIVERSITARI VALL DHEBRON - INSTITUT DE RECERCA ES +1
Combination products of at least three antibiotics comprising bedaquiline, pretomanid or delamanid, and a cytochrome BC1 inhibitor, and their use in the treatment of mycobacterial infections
PendingMDE20260410A1
Owner:JANSSEN PHARMA NV
Portable UV sterilising device with machine learning model
PendingMDE20260276A1
Owner:SHAHEEN INNOVATIONS HLDG LTD
Conjugate compositions comprising phosphoryl guanidine linkages and uses thereof
PendingMDE20260295A1
Owner:ATRIUM THERAPEUTICS INC
Pipe clamp, pipe clamp assembly and method for fastening the same
PendingMDE20260581A1
Owner:AKRAPOVIC D D
Injection device for a compressed-air engine, compressed-air engine provided with such a device and hybrid drive train comprising such an engine
PendingMDE20260502A1
Owner:VILLENEUVE PIERRE
Heteroaromatic compounds as muscarinic M4 receptor positive allosteric modulators (M4 PAMs)
PendingMDE20260670A1
Owner:SUVEN LIFE SCI LTD
Gemcitabine for use in methods of treating high-risk non-muscle invasive bladder cancer unresponsive to Bacillus Calmette-Guerin therapy
PendingMDE20260157A1
Owner:JANSSEN BIOTECH INC
Process for the production of liquid fuels using biomass gasification integrated with an electrolyzer
PendingMDE20260400A1
Owner:GREYROCK TECH LLC
Storage unit comprising a box and a lid provided with innovative means for coupling to said box
PendingMDE20260421A1
Owner:TONTARELLI SERGIO
PTK7 binding agents, conjugates thereof and methods of using the same
PendingMDE20260599A1
Owner:GENMAB AS
Methods of treating small cell lung cancer with lurbinectedin formulations
PendingMDE20260388A1
Owner:PHARMA MAR SA
Combination of a BTK inhibitor and a fumaric acid ester for use in the treatment of multiple sclerosis
PendingMDE20260210A1
Owner:BIOGEN MA INC
Hydrometallurgical method of production of iron, lead and silver, from residues of pyrometallurgical and hydrometallurgical metal production processes, using new, organic and inorganic, synthetic aqueous solutions
PendingMDE20260390A1
Owner:ARGYROPOULOS SOKRATIS
Use of cell switch assistance information for SSB searching during satellite switching
PendingMDE20260236A1
Owner:NOKIA TECHNOLOGIES OY
Compounds and pharmaceutical compositions that degrade SWI / SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A
PendingMDE20260327A1
Owner:PLEXIUM INC
Nitrogen-linked benzisoxazole sulfonamide derivatives for the treatment of cancer
PendingMDE20260626A1
Owner:PFIZER INC +1
Alcoholic beverages having a high content of fruity volatile compounds and a low volatile acidity and preparation process thereof
PendingMDE20260539A1
Owner:BIOENOLOGIA 2 0 SRL
Atomisation module and liquid container for a hookah
PendingMDE20260406A1
Owner:SHAHEEN INNOVATIONS HLDG LTD
Method of treating Crohn's disease with a combination of antibodies to IL-23 and TNF alpha
PendingMDE20260202A1
Owner:JANSSEN BIOTECH INC
Compositions and methods for the treatment of disorders related to glucosylceramidase beta 1 deficiency
PendingMDE20260204A1
Owner:VOYAGER THERAPEUTICS INC
Elsunersen / PRAX-222 for use in the treatment of SCN2A-related disorders
PendingMDE20260569A1
Owner:PRAXIS PRECISION MEDICINES INC
Cocrystal of an IDH1 inhibitor, process of preparation thereof, pharmaceutical compositions thereof, and methods of treatment involving the same
PendingMDE20260443A1
Owner:LES LAB SERVIER SA
Data-communication system and method of making data-communication
PendingMDE20260266A1
Owner:COGNITIVE RES LABS INC
TYK2 inhibitors and compositions and methods thereof
PendingMDE20260321A1
Owner:LYNK PHARMACEUTICALS CO LTD
Mist inhalation pod for delivering a therapeutic
PendingMDE20260259A1
Owner:SHAHEEN INNOVATIONS HLDG LTD
7-Difluorinated steroids for use in the treatment of neurological or mitochondrial diseases
PendingMDE20260583A1
Owner:CRISTAE THERAPEUTICS LTD
Methods of treating cancer associated with reduced interleukin 1 beta expression
PendingMDE20260705A1
Owner:CURIS INC
Antibody-like molecule comprising heterodimer of human CD1b (cluster of differentiation 1) protein
PendingMDE20260089A1
Owner:JOINT CO BIOCAD
Proteasome inhibitors and methods of use thereof
PendingMDE20260653A1
Owner:THE BRIGHAM & WOMEN S HOSPITAL INC +1
Compositions and methods for the treatment of disorders related to syntaxin-binding protein 1 deficiency
PendingMDE20260207A1
Owner:VOYAGER THERAPEUTICS INC
Anti-CD45 antibody-drug conjugate pharmaceutical compositions
PendingMDE20260593A1
Owner:REGENERON PHARMACEUTICALS INC
Nucleic acid off-switches and methods and uses thereof
PendingMDE20260140A1
Owner:GENERAL MEDICINES INC
Methods of treating nausea and vomiting disorders using anti-GFRAL antibodies
PendingMDE20260445A1
Owner:NGM BIOPHARMACEUTICALS INC
Multispecific antigen-binding molecule with improved internalization characteristics
PendingMDE20260610A1
Owner:GENMAB AS
Single-and multi-cytokine fusion proteins and uses thereof
PendingMDE20260328A1
Owner:FUSE BIOTHERAPEUTICS INC
Dynamic scheduling of electric vehicle bidirectional charging
PendingMDE20260611A1
Owner:E ON DIGITAL TECH GMBH +1
Polymorph as protein kinase Mek inhibitor, and preparation method therefor and use thereof
PendingMDE20250948A1
Owner:SHANGHAI KECHOW PHARMA INC
Synchronous brushless motor with axial flow, cryogenic plant comprising the motor and relative method of operation of the plant
PendingMDE20260562A1
Owner:ENERGY TECH SRL
Resin composition, molded body using same, and method for producing resin composition
PendingMDE20260314A1
Owner:SHIRAISHI CENT LAB +1
Methods of preparing modulators of sodium channels and solid forms of the same for treating pain
PendingMDE20260691A1
Owner:VERTEX PHARMACEUTICALS INC
Polynucleotides encoding norovirus VP1 antigens and uses thereof
PendingMDE20260232A1
Owner:MERCK SHARP & DOHME LLC